UNIT 7 Nursing management of patients with Immunological problems
๐ IMMUNE SYSTEM:
๐งฌ ๐นDefinition:
The immune system is a complex network of cells, tissues, organs, and molecules that defends the body against pathogens (bacteria, viruses, fungi, parasites) and abnormal cells.
๐งฑ ๐นComponents of Immune System:
๐ธ 1. Organs (Lymphoid Organs):
๐ง
Central Lymphoid Organs
๐ฆด
Bone Marrow โ produces all blood cells including lymphocytes
๐ง
Thymus โ site of T-cell maturation (T for Thymus)
๐
Peripheral Lymphoid Organs
๐
Lymph Nodes โ filter lymph, site for antigen interaction
๐งช Assist in diagnostic tests: skin allergy test, ELISA, biopsy
๐น B. Symptom Management:
๐ Administer medications: steroids, antihistamines, immunosuppressants
โ๏ธ Provide comfort: pain relief, rest, skin care
๐ Monitor for infections and implement isolation if needed
๐น C. Education and Counseling:
๐งด Teach skin care for autoimmune rashes
๐งฌ Educate about medication adherence and side effects
๐ Encourage immunization where indicated
๐ข Guide avoidance of allergens or known triggers
๐น D. Nutrition & Lifestyle Support:
๐ฅ Promote balanced, high-protein diet
๐ญ Encourage avoidance of smoking/alcohol
๐ง Promote stress management and adequate sleep
๐ง V. Key Points to Remember
Always assess risk of infection vs. risk of autoimmune flare
Monitor for medication side effects (long-term steroids can cause Cushing’s features)
Recognize early signs of anaphylaxis or immunosuppression
Build rapport for psychological support due to chronic nature of illness
๐ฆ HIV & AIDS:
๐ ๐นDEFINITION
๐ฌ HIV (Human Immunodeficiency Virus):
A retrovirus that attacks the bodyโs immune system, specifically the CD4โบ T-helper cells, leading to a gradual decline in immune function.
โ ๏ธ AIDS (Acquired Immunodeficiency Syndrome):
A late stage of HIV infection where the immune system becomes severely damaged, and the body is vulnerable to opportunistic infections and certain cancers.
๐ง Important: Not every HIV-positive individual develops AIDS if early diagnosis and antiretroviral therapy (ART) are provided.
๐งซ ๐นCAUSES (Mode of Transmission)
HIV is primarily spread through direct contact with certain body fluids from an infected person:
๐ Mode
๐ Details
๐ฉธ Blood
Transfusions with infected blood or sharing needles
๐ Sexual Contact
Unprotected vaginal, anal, or oral sex
๐คฑ Mother-to-Child
During pregnancy, childbirth, or breastfeeding
๐ Needle Sharing
IV drug users sharing contaminated needles
๐ฉน Occupational Exposure
Needle stick injuries in healthcare settings (rare)
๐งฌ Infected Organ Transplant
Receiving organs/tissues from an HIV+ donor
๐ซ HIV is NOT spread by:
Touching or hugging
Sharing utensils or toilets
Saliva, tears, or sweat (without blood)
๐งฌ ๐นTYPES OF HIV
There are two major types of HIV:
1๏ธโฃ HIV-1
๐น Most common worldwide
๐น More virulent and easily transmitted
๐น Subtypes: A, B, C, D, F, G, H, J, K
๐น Subtype B common in USA/Europe; Subtype C in India/South Africa
2๏ธโฃ HIV-2
๐น Less common and mostly found in West Africa
๐น Slower disease progression
๐น Less transmissible compared to HIV-1
๐ง Quick Comparison:
Feature
HIV-1
HIV-2
Prevalence
Worldwide
Mostly West Africa
Progression
Rapid
Slower
Infectivity
High
Lower
Response to ART
Good
May be resistant to some drugs
๐ฌ ๐น PATHOPHYSIOLOGY OF HIV/AIDS
๐งฌ Stepwise Progression:
๐ Entry of Virus (HIV) โค HIV enters the body via blood, semen, vaginal secretions, or breast milk. โค Virus targets CD4โบ T-helper cells (essential for immune defense).
๐งซ Viral Binding & Fusion โค HIV uses its gp120 protein to bind to CD4 receptors. โค Fusion allows viral RNA to enter the host cell.
๐งฌ Integration โค The viral DNA integrates into the hostโs DNA via integrase enzyme. โค Now the host cell starts producing HIV proteins.
๐งช Assembly & Release โค New viruses are assembled and released from the host cell, destroying it. โค Thousands of CD4โบ T cells die, weakening immune response.
๐ Immune System Collapse โค Progressive CD4 count drops โค Body becomes susceptible to opportunistic infections โ leads to AIDS
๐ง Key Point: The lower the CD4 count, the weaker the immune system.
๐จ ๐น STAGES WITH SIGNS & SYMPTOMS
๐ 1. Acute HIV Infection (Seroconversion phase)
๐ Within 2โ4 weeks after infection
โ ๏ธ Symptoms
๐ Description
๐ก๏ธ Fever
Often the first sign
๐คง Sore throat
Due to immune activation
๐ด Fatigue
Common and persistent
๐ค Headache
Flu-like symptoms
๐คฎ Nausea, rash, diarrhea
May occur together
๐ High viral load
Very infectious at this stage
๐ 2. Chronic HIV Infection (Asymptomatic or Latent Phase)
๐ Can last for years (7โ10 years or more)
โ Features
๐ Description
๐ No major symptoms
Person feels healthy
๐ป Gradual CD4 decline
Virus replicates silently
๐งฌ Persistent lymphadenopathy
Swollen lymph nodes
โ 3. AIDS (Late-Stage HIV)
๐ CD4 < 200 cells/mmยณ or presence of AIDS-defining illness
๐ฉธ Symptoms
๐ Examples
๐ฅ Recurrent infections
TB, pneumonia, fungal infections
๐ฟ Opportunistic diseases
Candidiasis, Kaposiโs sarcoma
๐ง Chronic diarrhea
Often persistent and debilitating
๐ฏ Neurological signs
Confusion, memory loss, dementia
๐ Oral thrush
White patches in mouth
๐ Weight loss
“Wasting syndrome”
๐ฆ Herpes, shingles
Reactivation of latent viruses
๐งช ๐น DIAGNOSIS OF HIV/AIDS
1๏ธโฃ Screening Tests (Detect antibodies or antigens):
๐งช Test
๐งฌ Details
ELISA (EIA)
Detects HIV antibodies; high sensitivity
Rapid Tests
Detects antibodies or antigens (results in 15โ30 mins)
Home Testing Kits
Finger-prick or oral fluid kits (e.g., OraQuick)
โ Positive ELISA should be confirmed with another test
๐ญ Avoidance of smoking, alcohol, substance abuse
๐ง Key Points:
โ ART is lifelong โ stopping it can cause resistance โ Adherence >95% is crucial to prevent drug resistance โ Early diagnosis = better prognosis โ ART does not cure HIV, but helps lead a near-normal life
๐ ๏ธ HIV & AIDS: Surgical Management
๐ ๐นOverview
Patients with HIV/AIDS are not typically treated with surgery for the virus itself, but they may require surgical interventions for:
๐งโโ๏ธ Refer to community-based HIV/AIDS support services
๐ง V. Key Nursing Tips:
โ Always use gloves & standard precautions โ Establish trust and therapeutic communication โ Respect patientโs confidentiality and autonomy โ Tailor teaching to individual literacy and language needs โ Monitor mental health and reduce social isolation
๐ ๐น NUTRITIONAL CONSIDERATIONS
๐ฌ HIV/AIDS increases metabolic demands, weakens the immune system, and may cause malnutrition, which further worsens immunity.
โ Goals of Nutrition Therapy:
๐ก Boost immunity
๐ช Maintain muscle mass
โ Prevent nutrient deficiencies
๐ Improve quality of life and treatment tolerance
๐งพ ๐ธ Recommended Dietary Guidelines:
๐ฝ๏ธ Aspect
โ Recommendations
Calories
High-calorie diet to prevent weight loss (35โ45 kcal/kg/day)
Proteins
High-protein intake (1.2โ2 g/kg/day) to build immune cells and repair tissue
๐ Monitor for wasting syndrome (severe weight and muscle loss)
๐ Interactions between ART drugs and food (some require fasting)
๐คข Manage side effects of ART: nausea, vomiting, diarrhea, anorexia
๐ฆท Ensure good oral hygiene โ mouth ulcers can affect intake
โ ๏ธ ๐น COMPLICATIONS OF HIV & AIDS
๐ A. Opportunistic Infections (OIs)
Pneumocystis jiroveci pneumonia (PCP)
Tuberculosis (TB)
Candidiasis (oral/esophageal)
Toxoplasmosis
Cytomegalovirus (CMV)
Herpes Zoster
๐ B. Neurological Complications
HIV-associated neurocognitive disorder (HAND)
HIV dementia
Peripheral neuropathy
Seizures
๐ C. Malignancies
Kaposiโs Sarcoma
Non-Hodgkinโs Lymphoma
Cervical cancer (women)
๐ D. Metabolic & Systemic Complications
Wasting syndrome
Lipodystrophy (fat redistribution)
Hyperlipidemia
Diabetes mellitus
Liver and renal dysfunction
๐ E. Psychosocial Complications
Depression
Anxiety
Social stigma and isolation
Non-adherence to ART
๐ ๐น KEY POINTS (Summary for Quick Revision)
โ HIV targets CD4โบ T-cells, weakening the immune system โ AIDS is the final stage of HIV infection โ ART is lifelong and must be taken with โฅ95% adherence โ Early diagnosis + proper management = prolonged survival โ Malnutrition is common โ needs high-protein, high-calorie diet โ Opportunistic infections & malignancies are major complications โ Nurses must ensure infection control, emotional support, and education
๐ EPIDEMIOLOGY OF HIV & AIDS
๐ ๐นDEFINITION OF EPIDEMIOLOGY
Epidemiology refers to the study of the distribution, patterns, causes, and control of diseases in populations.
๐ In the context of HIV/AIDS, it includes:
Incidence & prevalence
Modes of transmission
Affected populations
Trends & geographical distribution
Risk factors and preventive measures
๐ ๐ธGLOBAL EPIDEMIOLOGY (As per UNAIDS & WHO)
๐ Statistical Update (Approximate)
๐ Global Numbers
๐ฅ People living with HIV
~39 million worldwide
๐ New infections per year
~1.3 million (2023)
โฐ๏ธ AIDS-related deaths/year
~630,000 deaths
๐ ART coverage (globally)
~76% of diagnosed cases
๐ High-burden regions:
Sub-Saharan Africa (accounts for ~65โ70% of all global HIV cases)
South and Southeast Asia
Eastern Europe and Central Asia (rising incidence)
๐ฎ๐ณ ๐ธEPIDEMIOLOGY IN INDIA (According to NACO 2023-24)
๐ Parameter
๐ฎ๐ณ Indiaโs Status
๐งโ๐คโ๐ง Estimated people living with HIV (PLHIV)
~2.4 million
๐ New infections/year
~63,000
โฐ๏ธ AIDS-related deaths/year
~42,000
๐งฌ Adult HIV prevalence
~0.21%
๐ ART coverage
~75% of diagnosed individuals on ART
๐บ๏ธ High-prevalence states in India:
Maharashtra
Andhra Pradesh
Karnataka
Telangana
Tamil Nadu
Manipur & Mizoram (highest in Northeast India)
๐ ๐ธMODES OF TRANSMISSION (India-Specific %)
๐ป Mode
๐ Percentage Contribution
Unprotected heterosexual sex
~88%
Injecting drug use (IDU)
~2.6%
Homosexual/bisexual transmission
~2.4%
Parent-to-child transmission
~2.3%
Blood transfusion
<0.1% (due to strict screening protocols)
๐ ๐ธKEY RISK FACTORS
๐น Unprotected sex (especially multiple partners) ๐น Injecting drug use with shared needles ๐น Infected mother-to-child transmission ๐น STDs (increase susceptibility) ๐น Lack of awareness & education ๐น Social stigma โ Delayed testing and treatment ๐น Poor access to healthcare services
โ ABC Strategy โ Abstinence, Be faithful, Condom use โ ART (Antiretroviral Therapy) for all diagnosed โ PrEP & PEP โ Pre- and Post-Exposure Prophylaxis โ Safe blood transfusion practices โ Harm-reduction programs for IDUs โ Mother-to-child transmission prevention (free ART during pregnancy) โ Awareness campaigns through NACO, WHO, NGOs โ HIV testing and counseling centers (ICTCs)
๐ง ๐นKEY POINTS TO REMEMBER
โ HIV/AIDS remains a global pandemic with regional differences โ Highest burden in Sub-Saharan Africa & Southeast Asia โ In India, heterosexual transmission is the leading mode โ Focused interventions are essential for high-risk groups โ Early detection, ART access, education & de-stigmatization are crucial
๐ TRANSMISSION & PREVENTION OF TRANSMISSION OF HIV
๐ฆ ๐น MODES OF HIV TRANSMISSION
HIV (Human Immunodeficiency Virus) is transmitted when infected body fluids come in direct contact with another personโs bloodstream or mucous membranes.
๐ Major Body Fluids that Transmit HIV:
๐ฉธ Blood
๐งฌ Semen and pre-seminal fluid
๐ฆ Vaginal fluids
๐ฌ๏ธ Rectal fluids
๐ผ Breast milk
โ Saliva, sweat, tears, or urine do NOT transmit HIV unless visibly mixed with blood.
๐ ๐ธ MAIN ROUTES OF TRANSMISSION
๐งช Mode
๐ Description
๐ Unprotected Sexual Contact
Vaginal, anal, or oral sex with an HIV-positive person without using a condom
๐ Sharing Needles/Syringes
Among IV drug users, tattooing, or piercing with unsterilized tools
๐คฑ Mother-to-Child (Vertical Transmission)
During pregnancy, childbirth, or breastfeeding
๐ฉธ Transfusion of Infected Blood
Rare in modern healthcare due to strict screening
๐ฉน Occupational Exposure
Accidental needle-stick injuries in healthcare workers
๐งฌ Organ/Tissue Transplantation
If donor is HIV positive (rare with current testing protocols)
๐ซ ๐ธ HIV is NOT spread by:
โ Touching, hugging, or shaking hands โ Sharing food, utensils, or toilets โ Mosquito bites โ Coughing or sneezing โ Using the same swimming pool or gym
๐ก๏ธ PREVENTION OF HIV TRANSMISSION
๐ธ I. General Preventive Strategies
๐งญ Strategy
๐ Details
โ Use of Condoms
Always use male or female condoms correctly during intercourse
โ HIV Testing & Counseling
Regular testing for early detection & prevention
โ Monogamous Relationship
Reduce number of sexual partners
โ Education & Awareness
Promote knowledge on HIV, safe sex, and transmission routes
๐ผ Avoidance of breastfeeding if safe alternatives available
๐ถ ART for the newborn within 72 hours
๐งฌ Safe delivery methods (C-section if viral load high)
๐น C. Healthcare Workers
๐งค Use Personal Protective Equipment (PPE)
๐ฉน Careful needle disposal (sharps containers)
๐งช Post-Exposure Prophylaxis (PEP) within 72 hours if exposed
๐ธ III. Medical Prophylaxis Strategies
๐ Strategy
๐ Description
ART (Antiretroviral Therapy)
Reduces viral load in HIV-positive persons, preventing transmission (U=U)
PrEP (Pre-Exposure Prophylaxis)
Daily pill (e.g., Tenofovir + Emtricitabine) for high-risk HIV-negative individuals
PEP (Post-Exposure Prophylaxis)
Emergency ART within 72 hours of possible exposure, continued for 28 days
๐ Key Preventive Programs in India (Under NACO):
๐ป ICTC โ Integrated Counseling and Testing Centres
๐ ART centres โ Free antiretroviral drugs
๐งฌ PPTCT โ Prevention of Parent to Child Transmission
๐ Awareness campaigns: Red Ribbon Express, school-based education
๐ Blood Safety Program: 100% screening of donated blood
๐ KEY POINTS TO REMEMBER
โ HIV is transmitted through specific body fluids, not casual contact โ Sexual contact remains the most common route of transmission โ Consistent condom use, education, and ART adherence reduce risk โ Prevention of mother-to-child transmission (PMTCT) is highly successful โ PEP & PrEP are crucial for high-risk individuals โ Stigma reduction and open discussion promote prevention
๐ฉโโ๏ธ ROLE OF THE NURSE IN HIV & AIDS CARE
(Counseling, Health Education, and Home Care Considerations)
๐ง I. ROLE OF NURSE IN COUNSELING
Nursing counseling in HIV/AIDS involves emotional support, guidance, and therapeutic communication to help the patient and their family cope with the physical, psychological, and social aspects of the disease.
๐น 1. Pre-Test Counseling
๐ Explain the purpose, procedure, and implications of HIV testing
๐ง Alleviate fear or anxiety related to test results
๐ค Ensure confidentiality and informed consent
๐ก Assess risk behavior and knowledge levels
๐น 2. Post-Test Counseling
โ For HIV-negative clients: reinforce prevention, safe practices, and need for repeat testing if at risk
โ For HIV-positive clients:
Help them accept the diagnosis
Provide emotional and psychological support
Explain the chronic nature of the disease
Discuss treatment options (ART initiation)
Educate on transmission prevention
Address stigma and discrimination concerns
๐น 3. Family and Partner Counseling
๐จโ๐ฉโ๐ง Support disclosure of status to family or sexual partner
๐ Encourage partner testing and safe sex practices
๐ถ Counsel pregnant women on PMTCT (Prevention of Mother-to-Child Transmission)
๐น 4. Adherence Counseling
๐ Educate about importance of โฅ95% ART adherence
โฐ Support strategies like setting alarms, using pill boxes
โ Help manage side effects and promote follow-up visits
๐ II. ROLE OF NURSE IN HEALTH EDUCATION
Health education empowers individuals with knowledge, attitudes, and practices to live healthier and prevent transmission.
๐น 1. Patient-Centered Education
๐งฌ Basic understanding of HIV/AIDS, its transmission & non-transmission routes
๐ Importance of early ART initiation and regular CD4/viral load monitoring
๐ฌ Respect patient wishes and provide dignity in dying
๐ KEY POINTS FOR NURSES:
โ Maintain confidentiality at all levels โ Use non-judgmental and empathetic communication โ Be a link between the patient and other services (social, nutritional, medical) โ Encourage positive living with HIV โ treatment, relationships, employment โ Address stigma, myths, and discrimination โ Promote ART adherence, healthy habits, and hope
National AIDS Control Programme (NACP) โ India
๐๏ธ Overview
Established: 1992
Governing Body: National AIDS Control Organization (NACO), under the Ministry of Health & Family Welfare, Government of India
Objective: To prevent and control the spread of HIV/AIDS and provide comprehensive care and support to those affected
Implementation: Through State AIDS Control Societies (SACS) and District AIDS Prevention and Control Units (DAPCUs)โWikipedia+1Wikipedia+1
๐ Evolution of NACP
NACP Phase I (1992โ1999)
Focus: Awareness generation, establishing surveillance systems, ensuring safe blood transfusion services, and initiating targeted interventions for high-risk groups
Sampoorna Suraksha Kendras (SSK): One-stop centers providing prevention, testing, treatment, and care services for at-risk populations
Community-Based Screening: Enhancing early detection through outreach programs
Mission Sampark: Re-engaging people lost to follow-up in HIV care
Integration with Other Health Programs: Collaborating with TB, Hepatitis, and reproductive health services for comprehensive care
Legal Framework: Implementation of the HIV and AIDS (Prevention and Control) Act, 2017, ensuring the rights of people living with HIV โnaco.gov.in+1PrEPWatch+1
๐ Monitoring and Evaluation
Strategic Information Management System (SIMS): For data collection, analysis, and dissemination
Regular Surveillance: Conducting HIV Sentinel Surveillance and Integrated Biological and Behavioral Surveillance
Research and Evaluation: Undertaking operational research to inform policy and program decisions โ
๐ค Partnerships and Collaborations
International Agencies: Collaboration with UNAIDS, WHO, World Bank, and Global Fund
Non-Governmental Organizations (NGOs): Engaging NGOs for targeted interventions and community mobilization
Private Sector: Involving private healthcare providers in service delivery and awareness campaigns โWikipedia+1naco.gov.in+1
๐ Conclusion
The National AIDS Control Programme has evolved over the years to address the changing dynamics of the HIV/AIDS epidemic in India. Through its multi-pronged approach encompassing prevention, care, support, and treatment, NACP aims to achieve an AIDS-free India by 2030.
VARIOUS NATIONAL AGENCIES FOR HIV/AIDS IN INDIA
๐๏ธ 1. National AIDS Control Organization (NACO)
๐ Established: 1992
๐ข Under: Ministry of Health & Family Welfare, Government of India
๐ฏ Objective: To lead the national response to HIV/AIDS epidemic in India
โ Key Functions:
Formulation and implementation of National AIDS Control Programme (NACP)
Monitoring and evaluating ART, blood safety, STI/RTI management, and preventive services
Setting up ART Centres, ICTCs, STI Clinics, PPTCT programs
Collaborating with NGOs, civil society, and international partners
๐ซ 9. NGOs and Community-Based Organizations (CBOs)
NACO partners with more than 2000 NGOs and CBOs to reach high-risk and marginalized groups.
๐งก Roles:
Implement targeted interventions (TIs) for:
Female sex workers (FSWs)
Men who have sex with men (MSMs)
Injecting drug users (IDUs)
Transgender persons
Provide:
Community outreach
Peer education
Condom distribution
ART adherence support
Anti-stigma education
โ Examples: Naz Foundation, SAATHII, CARE India
๐ค Collaborative Agencies (Govt + Non-Govt):
Department of Women and Child Development โ HIV+ orphans & children care
Department of Social Justice โ HIV services for drug users & transgender persons
Ministry of Labour โ HIV workplace policies
National Rural Livelihood Mission (NRLM) โ Livelihood support for PLHIV
School Health Programs โ HIV awareness among adolescents
๐ KEY POINTS TO REMEMBER
โ NACO is the apex national agency under the MoHFW for HIV/AIDS control โ SACS and DAPCUs ensure state/district-level program execution โ ICMRโNARI, NIHFW, and NBTC support research, training, and blood safety โ NHM helps integrate HIV services with mainstream healthcare โ NGOs and CBOs are essential for reaching vulnerable populations
๐ VARIOUS INTERNATIONAL AGENCIES FOR HIV/AIDS:
๐๏ธ 1. UNAIDS (Joint United Nations Programme on HIV/AIDS)
๐ Established: 1996
๐ Headquarters: Geneva, Switzerland
๐ฏ Objective: To lead and inspire the global effort to end AIDS as a public health threat by 2030.
โ Key Functions:
Coordinating the HIV/AIDS response across 11 UN organizations
Publishing global data and strategic reports on HIV/AIDS
Supporting countries in achieving 95-95-95 targets
Advocacy for universal access to ART
Promoting rights-based and gender-sensitive HIV policies
๐งญ Member Organizations Include:
WHO, UNICEF, UNDP, UNFPA, UNESCO, World Bank, ILO, UN Women, WFP, UNHCR, and UNODC
โ International agencies play a vital role in funding, research, advocacy, and service delivery for HIV/AIDS control โ UNAIDS and WHO lead the global HIV strategy and policy โ The Global Fund and PEPFAR are the largest donors for HIV/AIDS programs worldwide โ UNICEF and MSF provide grassroots-level service delivery for women, children, and vulnerable populations โ These agencies partner with national governments, NGOs, and communities to build a comprehensive HIV response
๐ฆ INFECTION CONTROL PROGRAMME RELATED TO HIV/AIDS
๐ ๐นDefinition of Infection Control Programme
An Infection Control Programme includes policies, procedures, and practices aimed at preventing the transmission of infectious agents such as HIV in healthcare, community, and household settings. For HIV/AIDS, it focuses on universal precautions, safe practices, education, and monitoring to prevent spread.
๐งญ OBJECTIVES OF HIV INFECTION CONTROL PROGRAMME
๐ Prevent occupational exposure to HIV among healthcare workers
๐ Minimize nosocomial (hospital-acquired) HIV transmission
๐ซ Prevent community and vertical transmission
๐ Ensure safe blood and blood products
๐ฏ Promote universal precautions and safety culture
๐ Educate health workers, patients, and families about HIV prevention strategies
๐ฉบ KEY COMPONENTS OF HIV INFECTION CONTROL PROGRAMME
๐ธ 1. Universal Precautions
Universal precautions treat all blood and body fluids as potentially infectious.
โ Key Practices:
๐งค Wear gloves, mask, goggles for procedures with exposure risk
๐ Use disposable/single-use syringes and needles
๐ฎ Dispose of sharps in puncture-proof containers
๐งผ Hand hygiene before/after patient contact
๐งด Disinfect surfaces and instruments
๐งฅ Use PPE (personal protective equipment) appropriately
๐ธ 2. Standard Operating Procedures (SOPs)
Healthcare institutions follow SOPs for:
Safe handling of blood, secretions, and bodily fluids
๐ Train healthcare workers on infection control protocols
๐ฉบ Simulation exercises for needle stick prevention
๐ง Promote non-discriminatory care practices
๐ฌ Counseling and awareness on stigma reduction
๐ธ 7. Monitoring and Surveillance
๐ Continuous reporting of needle-stick injuries
๐งพ Internal audits and compliance checks
๐ National HIV surveillance via NACO and ICMR-NARI
๐ Documentation of PEP administration and ART follow-up
๐ธ 8. Integration with Other Programs
๐งฌ Link HIV infection control with TB control, STI/RTI services, and maternal health programs
๐ Referral system for HIV+ cases identified in hospitals or community
๐ NATIONAL SUPPORTIVE PROGRAMS
๐ข Agency
๐ก Contribution
NACO
Guidelines for HIV infection control & PEP
SACS
State-level training and ART implementation
NHM
Integration with primary healthcare
National Blood Safety Programme
Ensures safe transfusions
ICTCs & ART Centers
Entry points for prevention, testing, and care
โ KEY POINTS TO REMEMBER
โ HIV is not spread by casual contactโfocus is on blood, sexual, and vertical transmission โ Universal precautions must be followed in all healthcare settings โ PEP is effective if started within 72 hours โ Infection control programs reduce HIV transmission to zero in healthcare settings if strictly followed โ Continuous training, awareness, and monitoring are crucial
๐งโโ๏ธ REHABILITATION IN HIV & AIDS
๐ ๐นDefinition of Rehabilitation in HIV/AIDS
Rehabilitation for HIV/AIDS refers to a comprehensive and continuous process that helps restore, maintain, and improve the physical, emotional, social, and occupational functioning of individuals living with HIV/AIDS (PLHIV), especially as the disease progresses or complications arise.
๐ฏ OBJECTIVES OF HIV/AIDS REHABILITATION
๐ก๏ธ Maintain independence and functional capacity
๐ง Address mental and emotional well-being
๐ช Strengthen physical health and reduce disability
๐ผ Enable return to meaningful occupation and societal participation
๐จโ๐ฉโ๐ง Improve quality of life and reduce stigma
๐งฐ COMPONENTS OF REHABILITATION IN HIV/AIDS
๐ธ I. Physical Rehabilitation
โ Required for PLHIV experiencing:
Muscle weakness
Neuropathy
Wasting syndrome
Functional limitations due to opportunistic infections
โ Strategies Include:
๐๏ธโโ๏ธ Physiotherapy and graded exercise programs
๐ Psychiatric referrals if needed (for major depression, psychosis)
๐ธ III. Social Rehabilitation
โ Challenges include:
Social rejection and discrimination
Family disintegration
Loss of social roles and identity
โ Interventions:
๐จโ๐ฉโ๐ง Family education & involvement
๐ Reintegration into community & social groups
๐ Anti-stigma campaigns and awareness programs
๐งโโ๏ธ Social worker interventions and follow-up visits
๐ Linkages with NGOs and community-based organizations
๐ธ IV. Vocational Rehabilitation
โ PLHIV may suffer loss of job or income due to stigma or physical limitations.
โ Supportive Steps:
๐ผ Vocational counseling and career planning
๐ ๏ธ Skill training or retraining for new professions
๐ป Work-from-home or flexible job options
๐ค Job placement support through NGOs
๐ Legal aid for workplace discrimination
๐ธ V. Community-Based Rehabilitation (CBR)
CBR focuses on utilizing local community resources to support PLHIV in their environment.
โ CBR Includes:
๐งโโ๏ธ Home-based care models
๐ก Local health volunteers/ASHAs trained in HIV care
๐ Awareness and education sessions in villages or slums
๐ Mobile ART distribution in remote areas
๐ Participation in SHGs (Self Help Groups), cooperatives
๐งโโ๏ธ ROLE OF NURSES IN HIV REHABILITATION
๐ Area
๐งฉ Role
๐ง Psychological
Provide counseling, reduce fear, encourage expression
๐งด Physical
Encourage mobility, assess fatigue, assist with rehab exercise
๐ฌ Social
Educate family, advocate against stigma
๐ Vocational
Motivate skill building, refer for training
๐ Follow-up
Monitor drug adherence, nutritional intake, functional status
๐ค Coordination
Collaborate with physiotherapists, psychologists, social workers
๐ง KEY CHALLENGES IN HIV REHABILITATION
โ Stigma and discrimination from society/employers
๐ Low awareness and access to rehabilitation services in rural areas
๐ฐ Financial constraints limiting treatment and follow-up
๐ท Physical limitations due to opportunistic infections or comorbidities
โณ Lack of trained rehab personnel for chronic HIV cases
๐ KEY POINTS TO REMEMBER
โ Rehabilitation must be individualized and holistic โ Covers physical, psychological, social, vocational, and community aspects โ Early rehabilitation improves quality of life and life expectancy โ Nurses play a central role in coordination, care, and education โ Involvement of family, community, and NGOs enhances success
๐ PEP โ POST-EXPOSURE PROPHYLAXIS
๐ ๐นDEFINITION
Post-Exposure Prophylaxis (PEP) refers to the short-term antiretroviral treatment given to a person after potential exposure to HIV to prevent seroconversion (i.e., becoming HIV-positive).
๐ It is a medical emergency, and the treatment must begin within 72 hours of exposure.
๐ฏ ๐นOBJECTIVES OF PEP
โ Prevent establishment of HIV infection after accidental exposure
๐งฌ Inhibit viral replication during the early window period
๐ฉบ Protect healthcare workers, victims of sexual assault, and others at risk
๐ฆ ๐ธINDICATIONS FOR PEP
PEP is recommended when there is a substantial risk of HIV transmission, such as:
๐ Situation
๐ Details
๐ Occupational exposure
Needle-stick injury, blood splash into eyes/nose/mouth, exposure to broken skin from HIV+ source
๐ Non-occupational exposure
Unprotected sex, condom breakage, sharing of needles, sexual assault
๐คฐ Pregnant woman exposed
To prevent vertical transmission if recently exposed
๐งโโ๏ธ Healthcare providers
Accidental injury during care of known or suspected HIV+ patients
๐ ๐ธTIME FRAME
โณ PEP must be initiated within 72 hours (3 days) of exposure. โฑ๏ธ The sooner, the better โ ideally within 2 hours.
โ PEP is not effective if started after 72 hours.
๐ ๐ธPEP REGIMEN
According to NACO and WHO guidelines:
๐งช Drug
๐ Dosage
Tenofovir Disoproxil Fumarate (TDF) โ 300 mg
Once daily
Lamivudine (3TC) โ 300 mg
Once daily
Dolutegravir (DTG) โ 50 mg
Once daily
๐ Duration: 28 days (4 weeks) โ Can be given as a fixed-dose combination tablet in many settings
๐งช ๐ธINVESTIGATIONS BEFORE AND AFTER PEP
๐ฌ Baseline Testing (Before Starting PEP):
HIV antibody test (ELISA or Rapid)
Liver function test (LFT)
Renal function test (RFT)
CBC
Hepatitis B & C screening
Pregnancy test (if applicable)
๐งพ Follow-up HIV Testing:
At 6 weeks
At 3 months (12 weeks)
At 6 months (optional in some guidelines)
๐จโโ๏ธ ๐ธMONITORING DURING PEP
๐ฏ Adherence to daily medication
๐ Side effects (nausea, headache, fatigue)
โ LFTs and RFTs if patient develops symptoms of toxicity
๐ง Emotional/psychological support (especially after assault or high-anxiety events)
๐ง ๐ธROLE OF NURSE IN PEP MANAGEMENT
๐ Nursing Responsibility
๐ก Description
๐ Risk assessment
Identify exposure type, HIV status of source
โฑ Immediate action
Clean wound, refer for PEP initiation
๐ Documentation
Record exposure details, consent, regimen
๐ Drug administration
Educate about ART dosage and adherence
๐ค Counseling
Reduce anxiety, stigma, promote testing
๐ Follow-up
Schedule HIV tests and monitor drug compliance
โ WHEN PEP IS NOT REQUIRED
๐ค Casual contact (hugging, handshakes)
๐งผ Exposure to intact skin
๐ง Contact with non-blood body fluids (saliva, urine, sweat) unless visibly mixed with blood
๐งซ Source confirmed to be HIV-negative
โ ๏ธ PRECAUTIONS DURING PEP
Do not donate blood or body tissues
Use condoms consistently
Avoid breastfeeding (if applicable)
Monitor and report any side effects
Continue safer practices until follow-up tests are clear
๐ง KEY POINTS TO REMEMBER
โ PEP is not 100% effective, but highly successful when started early โ Must be initiated within 72 hours โ Full 28-day course is necessary โ Always do follow-up HIV testing โ Nurses play a crucial role in counseling, administration, and support